Get started
Author

Rafik Mesbah

Observed names: Mesbah, Rafik, Mesbah12, Rafik, R. Mesbah
ORCID: 0000-0001-6859-4851
Observed ORCID: 0000-0001-6859-4851
OpenAlex ID: A5000394576
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
2022 · Peter Rossing, Stefan D. Anker, et al. · Diabetes Care · 238
PDF
Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients
2020 · Cécile Couchoud, Florian Bayer, et al. · Kidney International · 148
PDF
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2023 · Rajiv Agarwal, Wanzhu Tu, et al. · Annals of Internal Medicine · 121
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan
2023 · Frank B. Cortazar, John L. Niles, et al. · Kidney International Reports · 102
PDF
A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren’s syndrome
2016 · Magali Jasiek, Alexandre Karras, et al. · Rheumatology · 81
PDF
Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
2022 · Sara Thietart, Alexandre Karras, et al. · JAMA Network Open · 47
PDF
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis
2025 · Patrick Rossignol, Faiez Zannad, et al. · The Lancet · 41
PDF
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
2022 · Peter Rossing, Ellen Burgess, et al. · Diabetes Care · 41
PDF
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
2023 · Vibeke Strand, David R W Jayne, et al. · The Lancet Rheumatology · 36
Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients
2023 · Julien Rohmer, Yann Nguyen, et al. · Journal of Autoimmunity · 34
PDF
An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study)
2018 · Philippe Rémy, Vincent Audard, et al. · Kidney International · 32
Clinical and Prognostic Factors in Patients with IgG4-Related Kidney Disease
2023 · Anis Chaba, Arnaud Devresse, et al. · Clinical Journal of the American Society of Nephrology · 28
Patients of 75 years and over with ANCA‐associated vasculitis have a lower relapse risk than younger patients: A multicentre cohort study
2021 · Sara Thietart, Guillaume Beinse, et al. · Journal of Internal Medicine · 22
Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis
2024 · Sophie Nagle, Yann Nguyen, et al. · Annals of the Rheumatic Diseases · 20
PDF
Treatment With Avacopan in ANCA–Associated Vasculitis With Kidney Involvement
2025 · Duvuru Geetha, Frank B. Cortazar, et al. · Kidney International Reports · 11
PDF
Rituximab resistance at 3 months of induction therapy in newly diagnosed or relapsing ANCA-associated vasculitis: A French multicentre retrospective study in 116 patients
2023 · Thomas Machet, Thomas Quémeneur, et al. · Joint Bone Spine · 11
Elastase-ANCA-associated idiopathic necrotizing crescentic glomerulonephritis--a report of three cases
2007 · A. Seidowsky, M. Hoffmann, et al. · Nephrology Dialysis Transplantation · 11
Differential Determinants of Tubular Phosphate Reabsorption: Insights on Renal Excretion of Phosphates in Kidney Disease
2018 · Nahid Tabibzadeh, Romuald Mentaverri, et al. · American Journal of Nephrology · 8
Histologic Features Associated with Kidney Survival in Scleroderma Renal Crisis
2025 · Yannick Binois, David Buob, et al. · Journal of the American Society of Nephrology · 6
PDF
ANCA-associated scleritis: impact of ANCA on presentation, response to therapy and outcome
2023 · Laura Perray, Yann Nguyen, et al. · Rheumatology · 6
PDF
Are serum C3 levels or kidney C3 deposits useful markers for predicting outcomes in patients with ANCA-associated vasculitis?
2023 · Alexis Cassard, Clément Kounde, et al. · Journal of Translational Autoimmunity · 4
Characteristics and prognostic significance of myelodysplasia-related features in VEXAS syndrome
2026 · Lin-Pierre Zhao, Olivier Kosmider, et al. · Leukemia · 3
Effect of Baseline Dialysis and Plasma Exchange on Renal Prognosis in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
2025 · Maxime Vignac, Dorian Nezam, et al. · Kidney International Reports · 3
The predictive performance of the ANCA renal risk score in patients over 65 years of age with renal ANCA-associated vasculitis
2024 · Quentin de Berny, Momar Diouf, et al. · Clinical Kidney Journal · 2
Spectrum of Anti–Factor B-Associated Glomerular Diseases in Adults
2026 · Romain Brousse, Julia Roquigny, et al. · American Journal of Kidney Diseases · 1
Works count: 42
Citation count: 1,096
H-index: 15
I10-index: 18
Year
Topic
Type